亞洲知識產權資訊網為知識產權業界提供一個一站式網上交易平台，協助業界發掘知識產權貿易商機，並與環球知識產權業界建立聯繫。無論你是知識產權擁有者正在出售您的知識產權，或是製造商需要購買技術以提高操作效能，又或是知識產權配套服務供應商，你將會從本網站發掘到有用的知識產權貿易資訊。

返回搜索結果

Novel Therapeutic Approach for the Treatment of Autism Spectrum Disorders

詳細技術說明

Based on these discoveries, the UC San Diego researchers have developed a therapeutic approach for the treatment of autistic spectrum disorder using the targeted delivery of agents that can enable the mutated neuroligin molecule to reach the cell surface and bind effectively to beta-neurexin-1. The invention may have additional applications in the treatment of diseases characterized by abnormal trafficking of adhesion molecules.

附加資料

Patent Number: US7972601B2
Application Number: US2006596160A
Inventor: Taylor, Palmer | Comoletti, Davide | Jennings, Lori | Flynn, Robyn
Priority Date: 11 May 2004
Priority Number: US7972601B2
Application Date: 8 Nov 2006
Publication Date: 5 Jul 2011
IPC Current: A61K003900 | A01N003718 | A61K0039385 | A61K004800 | C07K0014705 | C12N001585 | G01N003368
US Class: 4241851 | 4241921 | 4241941 | 5140013 | 5140177 | 514002 | 514018
Assignee Applicant: The Regents of the University of California
Title: Method of promoting delivery of an antioxidant agent to a cell expression neuroligin
Usefulness: Method of promoting delivery of an antioxidant agent to a cell expression neuroligin
Summary: (M1) is useful for targeting an agent to a cell expressing neuroligin. (M2) is useful for treating an autism spectrum disorder in a subject, where the subject is a mammal, preferably human. A1 or (I) is useful for screening an agent for use in treating autism spectrum disorders, which involves contacting A1 or (I) with the agent, and measuring the amount of neuroligin-3 intracellularly in the treated animals compared to a control (claimed).
Novelty: Targeting agent e.g. sulfur-containing antioxidant such as glutathione, to cell expressing neuroligin, involves linking agent to molecule interacting with binding domain of neuroligin